AI assistant
Sending…
REVVITY, INC. — Director's Dealing 2004
Nov 12, 2004
30616_dirs_2004-11-12_f77685d7-1502-455b-9e49-41e048c5a6d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2004-11-05
Reporting Person: Roush John A (Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7919 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| NQ Stock Option (Right to Buy) | $13.88 | 2006-04-12 | Common Stock (30000.00) | Direct | |
| NQ Stock Option (Right to Buy) | $19.83 | 2007-01-07 | Common Stock (16000.00) | Direct | |
| NQ Stock Option (Right to Buy) | $44.33 | 2008-01-05 | Common Stock (15000.00) | Direct | |
| NQ Stock Option (Right to Buy) | $30.86 | 2008-04-25 | Common Stock (15000.00) | Direct | |
| NQ Stock Option (Right to Buy) | $32.40 | 2009-01-16 | Common Stock (5000.00) | Direct | |
| NQ Stock Option (Right to Buy) | $12.23 | 2009-05-01 | Common Stock (20000.00) | Direct | |
| NQ Stock Option (Right to Buy) | $8.16 | 2010-01-22 | Common Stock (25000.00) | Direct | |
| NQ Stock Option (Right to Buy) | $19.84 | 2011-01-27 | Common Stock (15000.00) | Direct |
Footnotes
F1: The reporting persons direct holdings include an aggregate of 2,919 shares acquired pursuant to the deferral of compensation into (i) the Employee Stock Purchase Plan, and/or (ii) reinvestment of dividends relating to the reporting person's account.
F2: This option vests equally, in thirds, over a three year period and has a 7 year exercise term.
More from REVVITY, INC.
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 5
Declaration of Voting Results & Voting Rights Announcements
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Proxy Solicitation & Information Statement
2026
Mar 16
Regulatory Filings
2026
Mar 6